# Camrelizumab Utilization on Patients With Advanced Liver Cancer

> **NCT04487704** · NA · UNKNOWN · sponsor: **First Affiliated Hospital Xi'an Jiaotong University** · enrollment: 1000 (estimated)

## Conditions studied

- Advanced Hepatocellular Carcinoma

## Interventions

- **OTHER:** camrelizumab

## Key facts

- **NCT ID:** NCT04487704
- **Lead sponsor:** First Affiliated Hospital Xi'an Jiaotong University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-04-07
- **Primary completion:** 2023-01-01
- **Final completion:** 2025-01
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2022-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04487704

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04487704, "Camrelizumab Utilization on Patients With Advanced Liver Cancer". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT04487704. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*